Q2 2019

Source filing unavailable

Q2 2019 · —

Revenue—

Net Income

$6.80B

−12.5% vs Q2 2018

EPS Diluted

$2.91

−12.1% vs Q2 2018

Gross Profit$8,618,000,000−4.0%

Operating Income$2,663,000,000+7.2%

Operating Cash Flow$3,111,000,000−21.1%

Same quarter

Metric	Q2 2019	Q2 2018	Q2 2017
Net Income	$6.80B	$7.77B	$1.98B
EPS Diluted	$2.91	$3.31	$0.83

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Novartis AG · CIK 1114448 · Engraved from SEC EDGAR